SENSEX NIFTY

Buy or wait wonder investors as Sensex dives 807pts, Nifty sub 7000

Top multi bagger recommendations in 2014

Did you invest in these stocks?

Company Name Reco Date Reco Price Peak
from Reco
Gain %
APL Apollo Tubes Oct 12th 2015 538 839.50 56.16
NIIT Technologies Sep 24th 2015 449 632.00 40.87
Astec LifeSciences Mar 31st 2015 141 304.00 116.22
Zensar Technologies Mar 24th 2015 623 1120.00 79.78
Minda Industries Feb 24th 2015 592 996.00 68.39

Stock Quote

GET QUOTE

Market Action

SENSEX
 
NIFTY 50
 
Nasdaq (Feb 12) 4266.84 -16.75 -0.39%
FTSE (Feb 11) 5536.97 -135.33 -2.39%

See all global markets »

Gold - Apr 05 29,735.00 1,418.00 5.01%
Silver - Mar 04 38,170.00 1,390.00 3.78%
Naturalgas - Feb 24 136.50 -2.00 -1.44%
Crudeoil - Feb 19 1,850.00 -49.00 -2.58%

See all commodity prices »

Dollar / Rupee 68.29 0.44 0.66%
Euro / Rupee 77.40 -0.10 -0.13%
Pound / Rupee 99.03 0.51 0.52%

View all exchange rates »

NHAI - N2 1,100.88 -3.62 -0.33%
Rec - N9 1,128.05 -3.95 -0.35%
Ntpc - N6 1,153.50 3.20 0.28%

View all listed bonds »

Views from the Investor Community
 

Suresh Bhagavatula

Assistant Professor , IIM-Bangalore
(12 Feb- 13:00hrs)

Entrepreneurship & Social Networks

LIVE NOW
COMING UP
7.00
POWER BREAKFAST
7.30
POWER BREAKFAST

Corporate Action

Board Meetings
Company Name
Agenda
Quarterly Results & Others
Quarterly Results
Quarterly Results
AGM / EGMs
Bonus
Splits
Rights
Dividend
by
COMPANY NAME
Last Price
Change
MARKET CAP
Net SAles
Net Profit
Assets
2197.95
-70.85
433,090.21
73578.06
19256.96
42,363.14
924.55
-38.10
299,521.23
329076.00
22719.00
304,770.00
1078.65
-29.90
247,759.94
47300.00
12164.00
45,619.00
975.30
-37.65
246,369.86
48469.90
10215.92
502,592.26
298.55
-10.45
239,982.21
36507.40
9607.73
30,480.85
Result Screener
Valuation Statistics

moneycontrol

Subscribe to our newsletters

Sign up

Profit from the
Markets

With
Sudarshan Sukhani
Profit from the
Markets

With
C K Narayan
Profit from the
Markets

With
T Gnanasekar
Profit from the
Markets

With
Ambareesh Baliga
Profit from
currencies

NEWS FLASH

  • Sun Pharma : Imatinib Mesylate Is Therapeutic Equivalent To Gleevec
  • Sun Pharma : Launches Imatinib Mesylate In US
  • Balaji Tele : To Mull Fundraising Via Issue Of Securities On Pref Basis On February 4

Now Playing

LESSONS IN MARKETING EXCELLENCE

Interact with CNBC-TV18

Post Your Query

Your Stocks

Send in your queries and have them answered by our experts at CNBC-TV18

Your Details

Market Masters

Send in your queries and have them answered by our experts at CNBC-TV18

Your Details

Your Opinion Matters

 

Stay invested, market quite cheap: Nilesh Shah. Will you put money in a mutual fund now? 65 comments

Do you see Nifty holding 7,000 mark? 111 comments

Will Make In India Week boost innovation in India? 2 comments

Infosys down sharply reacting to Cognizant`s guidance. Will you buy the stock now? 49 comments

  What's your opinion?
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.